Whether chronic OSA could promote EAT-secreting profibrotic adipokines and thereby contribute to the fibrosis of neighboring atrial myocardium remains unknown. Increased sympathetic activity is 1 of the most important mechanisms underlying OSA-related myocardial damage and OSA-induced AF. 11, 12 We previously found that the b-adrenergic receptor antagonist metoprolol could inhibit atrial structural, autonomic, and metabolic remodeling and AF inducibility in a canine model of chronic OSA. 13 However, the potential regulatory effects of metoprolol on the profibrotic adipokines secretion of EAT in chronic OSA are still unclear. Therefore, in the present study, we tested whether chronic OSA could promote EAT-secreting profibrotic adipokines and thereby contribute to the fibrosis of neighboring atrial myocardium, and whether metoprolol could play a protective role in a canine model of chronic OSA.
Materials and Methods
The data that support the findings of this study are available from the corresponding authors on reasonable request.
Animals and Animal Models
Twenty-one healthy male mongrel dogs (15-20 kg, Experimental Animal Center of the First Affiliated Hospital of Harbin Medical University, Harbin, China) were used in the study. The present study was performed in accordance with the Guide for the Care and Use of Laboratory Animals and was approved by the Institutional Animal Care and Use Committee at the Harbin Medical University. The dogs were randomly divided into 3 groups: Sham group (n=7), OSA group (n=7), and OSA-and metoprolol-treated group (OSA+Met group, n=7). The chronic OSA model was conducted as previously described. 13 The dogs were anesthetized with intravenous ketamine (5.3 mg/kg), diazepam (0.25 mg/kg), and xylazine (1 mg/kg), and the adequacy of anesthesia was monitored on the basis of the disappearance of the corneal reflex and jaw tone. Then, tracheal intubation was performed, and the tracheal tubes were clamped to induce apnea at the end of the exhalation. In the first week the duration of the trachea blockage was 1 minute, and the duration of ventilation was 9 minutes. Thus, the apneahypopnea index was set as 6. For the next 3 weeks, the duration of trachea blockage remained unchanged while the duration of ventilation was reduced by 1 minute every week. During the last 8 weeks the duration of trachea blockage was still 1 minute, and the duration of trachea ventilation was 5 minutes (apnea-hypopnea index was 10). The procedure of trachea blockage and ventilation was performed for 4 hours every other day over 12 weeks. The dogs in sham group underwent anesthesia and tracheal intubation only. The dogs in OSA+Met group were administered metoprolol succinate (5 mg/kg per day) daily at the beginning of OSA simulation, and this regimen continued for 12 weeks.
Hematoxylin and Eosin and Masson Trichrome Staining
Atrial samples were collected in 4% paraformaldehyde and then embedded in paraffin. Left atrial (LA) EAT and its underlying atrial myocardium were stained with hematoxylin and eosin and Masson trichrome staining, respectively. Adipose tissue areas in the atrial myocardium at the junction between EAT and the atrial myocardium were measured on 3 randomly selected microscopic fields (9200), each slice analyzed with Image-Pro Plus software (Version 4.0, Media Cybernetics, LP, Rockville, MD) and expressed as a mean percentage of total field area (adipose infiltration fraction). The collagen volume fractions of EAT and the adjacent atrial myocardium were calculated by averaging the percentage area of stained tissue within 3 randomly selected microscopic fields (9200) on each slice using Image-Pro Plus software.
Immunohistochemical Studies
Activin A, transforming growth factor-b1 (TGF-b1), matrix metalloproteinase-9 (MMP-9), tumor necrosis factor-a (TNFa), and interleukin-6 (IL-6) were stained on 5-lm transmural sections of LA EAT. The sections were incubated overnight at 4°C with primary antibody (Biosynthesis Biotechnology Co Ltd, Beijing, China) and with peroxidase-conjugated second antibody (Zhongshanjinqiao Biotech, Beijing, China) at 37°C for 20 minutes. Then, they were visualized with a DAB-based colorimetric method.
Clinical Perspective
What Is New?
• The present study demonstrated that chronic obstructive sleep apnea enhanced the profibrotic effect of epicardial adipose tissue on the neighboring atrial myocardium by stimulating the secretion of profibrotic adipokines such as activin A, transforming growth factor-b1, matrix metalloproteinase-9, tumor necrosis factor-a, and interleukin-6 from epicardial adipose tissue, which was significantly attenuated by metoprolol.
What Are the Clinical Implications?
• These findings suggest that the autonomic nervous system plays an important role in chronic obstructive sleep apneainduced atrial fibrillation, and modulation of the sympathetic nervous system might help to prevent atrial fibrillation in patients with obstructive sleep apnea.
Enzyme-Linked Immunosorbent Assay
The activin A, TGF-b1, MMP-9, TNF-a, and IL-6 levels of LA EAT and the culture medium of 3T3-L1 cells were measured using ELISA kits (BlueGene Biotech Co Ltd, Shanghai, China) according to the manufacturer's instructions.
3T3-L1 Adipocyte Differentiation and Hypoxic Treatment
Murine preadipocytes (3T3-L1 cells) were obtained from American Type Culture Collection (Manassas, VA) and cultured in DMEM containing 10% FBS and 1% penicillin/streptomycin (growth medium) in a 5% CO 2 humidified atmosphere at 37°C. When the cells were subconfluenced at the culture bottle bottom, cell seeding was performed in 6-well plates. 3T3-L1 cells were differentiated into adipocytes according to previously described methods. 14 Briefly, 3T3-L1 cells were cultured to confluence completely, supplemented with 250 nmol/L dexamethasone, 25 nmol/L insulin, and 0.5 mmol/L isobutyl methylxanthine for 72 hours. Cells were then cultured for an additional 5 days in growth medium. Differentiation was determined microscopically with the criteria that fat droplets were observed in cytoplasm. Fully differentiated adipocytes were divided into 3 groups (Normoxia, Hypoxia, and Hypoxia+Metoprolol). In Hypoxia and Hypoxia+Metoprolol groups, cells were treated with vehicle and metoprolol (10 lmol/L), respectively, and then were incubated in a hypoxic chamber at an atmosphere of 1% O 2 , 95% N 2 , 5% CO 2 and at 37°C for 12 hours. In the Normoxia group, cells were incubated in an atmosphere of 21% O 2 and 5% CO 2 at 37°C for 12 hours. Then the conditioned medium was collected to culture cardiac fibroblasts (CFs). Moreover, the cytokine concentration in the conditioned medium was measured by ELISA.
CF Isolation and Culture
Primary cultures of rat CFs were isolated from the hearts of 1-to 2-day-old Sprague-Dawley rats using an enzymatic digestion solution containing 0.25% trypsin (Beyotime Institute of Biotechnology, Jiangsu, China) at 37°C. Cell cultures were incubated at 37°C in a humidified atmosphere of 5% CO 2 /95% air. CFs (second or third generation) were grown to subconfluence in serum-containing medium and then growth arrested for 24 hours in serum-free medium and were incubated with 3T3-L1 adipocyte-conditioned medium for 24 hours.
Western Blotting
Proteins were separated by electrophoresis on 8% to 12% SDS-polyacrylamide gels and transferred moist to polyvinylidene difluoride membranes. Membranes were blocked by 5% nonfat dry milk in PBS and incubated overnight at 4°C. Membranes were washed with PBS containing 0.5% Tween 20 and incubated with primary antibodies overnight, then incubated with horseradish peroxidase-conjugated secondary antibody (Zhongshanjinqiao Biotech, Beijing, China) for 1 hour. Antibodies against collagen I and collagen III were purchased from Biosynthesis Biotechnology Co, Ltd (Beijing, China). Antibodies against a-smooth muscle actin was obtained from Abcam (Cambridge, MA). Antibody against TGF-b1 was provided by Sigma-Aldrich (St. Louis, MO). The images were captured on the Bio-Rad system (Hercules, CA), and GAPDH (Kangcheng, Shanghai, China) was used as internal control.
Determination of Cell Viability
CF viability was detected using the CCK-8 assay (Dojindo Molecular Technologies, Inc, Kumamoto, Japan). CFs were plated in 96-well plates,with 5 duplicate wells in each group. When the cells had grown to %70% to 80% confluence, the cells were treated with conditioned medium as indicated. The CCK-8 solution (10 lL) at a 1:10 dilution with FBS-free DMEM (100 lL) was added to each well, and plates were incubated for 3 hours at 37°C. Absorbance was measured at 450 nm with a microplate reader (Molecular Devices, Sunnyvale, CA). The mean optical density (OD) of 5 wells in the indicated groups was used to calculate the percentage of cell viability as follows: percentage of cell viability=(OD treatment group -OD blank group )/ (OD control group -OD blank group )9100%.
Statistical Methods
All data are presented as the meanAESD. Multiple group comparisons were performed via 1-way ANOVA followed by Tukey tests. Natural logarithmic transformation was performed if the data did not satisfy statistical criteria for normal distribution, and the data were presented on the original scale. Analyses were conducted with GraphPad Prism version 5.0 (GraphPad Software, Inc, La Jolla, CA). P<0.05 was considered statistically significant.
Results
Metoprolol Attenuated OSA-Induced Fibrosis and Infiltration of EAT
As shown in Figure 1 , the fibrosis and the infiltration of EAT into atrial myocardium was significantly pronounced in chronic OSA dogs compared with those from the Sham group. Metoprolol significantly attenuated OSA-induced fibrosis and infiltration of EAT.
Metoprolol Alleviated the Profibrotic Effect of EAT Induced by OSA
To investigate the effects of EAT on the fibrosis of the neighboring atrial myocardium, we examined the interstitial fibrosis of LA myocardium that was covered by EAT. As shown in Figure 2 , Masson trichrome staining showed significantly more collagen deposition in the LA myocardium at the junction with EAT in OSA group than in that of Sham group, and the collagen deposition was observed around the infiltrated adipocytes. Treatment with metoprolol significantly attenuated the fibrosis of LA myocardium. These results suggested that OSA enhanced the profibrotic effect of EAT on the atrial myocardium beneath it, which was inhibited by metoprolol treatment.
Metoprolol Inhibited Adipokine Secretion From EAT Induced by OSA
To illustrate the mechanism of the enhanced profibrotic effects of EAT during OSA, the expressions of main adipokines secreted by EAT were identified using immunohistochemistry and ELISA. The immunohistochemistry showed that the expressions of profibrotic and proinflammatory factors including activin A, TGF-b1, MMP-9, TNF-a, and IL-6 were significantly increased in EAT of OSA dogs over those in sham dogs (Figure 3 ), which was also confirmed by ELISA (Figure 4) . OSA-induced upregulation of these adipokines in EAT could be reduced by metoprolol treatment (Figures 3 and 4) .
Metoprolol Inhibited Hypoxia-Induced Adipokine Secretion in 3T3-L1 Cells
To evaluate the effect of hypoxia on adipokine secretion, we measured the main adipokine concentration in the culture medium of 3T3-L1 cells after 12 hours of hypoxia exposure using ELISA. The experiment was performed in quadruplicate. As shown in Figure 5 , hypoxia significantly increased the secretion of activin A, TGF-b1, and IL-6 but had no significant effect on MMP-9 or TNF-a. Metoprolol treatment blocked hypoxia-induced increase in activin A, TGF-b1, and IL-6.
Hypoxic 3T3-L1 Adipocyte-Derived Conditioned Medium Increased CF Collagen Synthesis, TGF-b1 Expression, and Cell Proliferation
We further observed the effect of the hypoxic 3T3-L1 adipocyte-derived conditioned medium on collagen synthesis and TGF-b1 expression in CFs. The experiment was performed in quadruplicate. The results showed that there was a significant increase in collagen I, collagen III, and TGF-b1 protein expression in CFs treated with hypoxic 3T3-L1 adipocyte-derived conditioned medium for 24 hours compared with cells subjected to normal culture medium ( Figure 6A through 6C) . We also observed the effect of the hypoxic 3T3-L1 adipocyte-derived conditioned medium on cell differentiation and proliferation in CFs. As shown in Figure 6D , the differentiation marker a-smooth muscle actin did not exhibit a statistical significance, although there was an increasing tendency. The hypoxic 3T3-L1 adipocyte-derived conditioned medium led to an increase in cell viability determined by the CCK-8 kit (Figure 6E ), which indicated increased proliferation of CFs. Furthermore, compared with the adipocyte-derived conditioned medium from the Hypoxia group, the adipocyte-derived conditioned medium from the Hypoxia+Metoprolol group significantly inhibited collagen I, collagen III, and TGF-b1 protein expression and cell proliferation of CFs.
Discussion
To our knowledge, the present study was the first experimental analysis of the contributory effect of EAT on the fibrosis of the underlying atrial myocardium, and the protective role of metoprolol during chronic OSA. We found that EAT promoted the fibrosis of the adjacent atrial myocardium, and the effect was enhanced by chronic OSA in a canine model. Moreover, chronic OSA induced profibrotic and proinflammatory cytokine secretion from EAT. We also found hypoxiainduced adipokine secretion in cultured 3T3-L1 adipocytes, and the hypoxic adipocyte-derived conditioned medium increased collagen and TGF-b1 protein expression and cell proliferation of CFs. More importantly, the protective role of metoprolol was observed both in vivo and in vitro.
Previous studies showed a close relationship between the amount of LA EAT and AF independently of other AF risk factors as reviewed by Wong et al. 8 Interestingly, a recent study demonstrated that epicardial fat thickness was associated with OSA severity. 15 The promoting effect of EAT on atrial structural and electrical remodeling was thought to contribute to the association between EAT and AF. [4] [5] [6] [7] Atrial fibrosis is the most prominent feature of clinical AF and a key process of arrhythmogenic structural remodeling, which provides a basis for unidirectional conduction block and macro reentry, resulting in an AF substrate. 16 Studies showed that EAT could contribute to the fibrosis of neighboring atrial myocardium by secreting profibrotic factors including inflammatory cytokines, growth factors, and matrix metalloproteinases. Venteclef et al found the secretome from human EAT can promote myocardial fibrosis through the secretion of activin A. 9 Recently, Abe et al demonstrated that, in AF patients, the total collagen in the LA myocardium was positively correlated with proinflammatory and profibrotic cytokines/chemokines, including IL-6, monocyte chemoattractant protein-1, TNF-a, vascular endothelial growth factor, MMP-2, and MMP-9 in EAT. 10 Consistent with the above studies, our results showed that the expressions of profibrotic and proinflammatory factors including activin A, TGF-b1, MMP-9, TNF-a, and IL-6 were significantly increased in EAT of OSA dogs. In addition to the well-known profibrotic cytokines such as activin A, 9 TGFb1, 17 and MMP-9, 18 the proinflammatory factors TNF-a 19 and IL-6 20 have been proven to induce atrial fibrosis.
Therefore, the OSA-induced upregulation of profibrotic and proinflammatory factors may be the main mechanism of the profibrotic effect of EAT. In this study we found that OSA induced epicardial adipocyte infiltration into atrial myocardium, which might facilitate the diffusion of adipokines into atrial myocardium and thereby contribute to the profibrotic effect of these adipokines. Several pathophysiological consequences of OSA, including intermittent hypoxia, excessive arousals, increased sympathetic activation, and large negative intrathoracic pressure swings may provoke cardiovascular injury. Among the pathophysiological triggering factors, hypoxia has been suggested to play a key role in the pathophysiology of morphological and functional changes of the adipose tissue in OSA. 21 Almendros et al found that changes in visceral adipose tissue partial pressure of oxygen in lean rats during intermittent hypoxia or obstructive apnea cycles of comparable duration were blunted. 22 Therefore, to recapitulate the profibrotic remodeling of EAT induced by OSA, we evaluated the effect of hypoxia on adipokine secretion and further observed the profibrotic effect of the secretome in vitro. As a result, we found that 12 hours of hypoxia induced a significant increase in the secretion of activin A, TGF-b1, and IL-6 in 3T3-L1 adipocytes, and the hypoxic adipocytederived secretome exerted a profibrotic effect on CFs. Previous studies have demonstrated that hypoxia could modulate the expressions of classic adipokines such as adiponectin and leptin in rodent and human adipocytes. 23, 24 A recent study showed that chronic intermittent hypoxia induced a proinflammatory phenotype of visceral adipose tissue with proinflammatory M1 macrophage polarization in a murine model of obstructive sleep apnea. 25 In cultured 3T3-L1 adipocytes 26 and human adipocytes, 27 increased expression of inflammation-related adipokines such as IL-6 and monocyte migration inhibitory factor was observed during hypoxia. Therefore, it is reasonable to conclude that hypoxia is the main cause of adipokine secretion from EAT induced by OSA. Of note, there was a discrepancy in MMP-9 and TNF-a expressions between EAT of dogs with OSA and 3T3-L1 adipocytes with hypoxia treatment. There are 2 explanations for the discrepancy. First, it may be due to the difference in duration and degree of hypoxia. Second, the adipokine profile of epicardial adipocytes and 3T3-L1 adipocytes may differ because it has been reported that there is a difference in concentration of several adipokines between EAT-conditioned media and subcutaneous adipose tissue-conditioned media in patients. 9 There is evidence suggesting that hypoxia is also a major initiating factor for fibrosis of adipose tissue and that hypoxia-inducible factor1a plays a critical role in the fibrotic response as reviewed by Sun et al. 28 Recently, the fibrotic response and overexpression of hypoxia-inducible factor-1a were also observed in LA EAT in AF patients. 10 Therefore, the fibrosis of EAT induced by OSA in this study also could be attributed to hypoxia. Several studies have reported that the sympathetic nervous system regulates the expression of several adipokines through adipocyte adrenergic receptors. The nonselective b-adrenergic receptor agonist isoproterenol has been found to stimulate proinflammatory cytokines TNF-a and IL-6 expression in differentiated 3T3-L1 adipocytes. 29, 30 Consistently, the nonselective b-adrenergic receptor blocker propranolol has been proven to block acute stroke-induced TNF-a upregulation of epididymal adipose. 31 A previous study demonstrated that acute hypoxia in adipocytes caused dysregulation of adiponectin secretion, and this effect was accompanied by increased protein expression of b 1 and b 2 adrenergic receptors, 32 which indicates that b-adrenergic receptors may be involved in this process. In our present study we found that the b 1 -adrenergic receptor blocker metoprolol inhibited chronic OSA-or hypoxia-induced adipokine secretion in both EAT and 3T3-L1 adipocytes. Our result suggests that the regulatory effect of hypoxia on the expression of adipokines seems to depend mainly on adipocyte adrenergic receptor activation. The efficacy of b-adrenergic receptor blockers in the prevention of AF after heart surgery in patients has been confirmed in several clinical trials and meta-analyses. 33 Moreover, metoprolol therapy has been found to antagonize atrial gap junction remodeling and conduction in human chronic AF. 34 Despite the reported benefits, the use of badrenergic receptor blockers in OSA patients may be limited by their potential influence on apnea-induced bradycardia. However, a recent study showed that b-adrenergic receptor blockers attenuated apnea-induced increases in heart rate but did not potentiate apnea-induced heart rate decreases in patients with hypertension and OSA. 35 We previously found that metoprolol could inhibit atrial structural, autonomic, and metabolic remodeling and AF incidence in the canine model of chronic OSA. 13 Consistent with that, in this study, we found that metoprolol inhibited the profibrotic effect of EAT enhanced by chronic OSA as well. The sympathetic nervous system can be modulated by b-adrenergic receptor antagonists and renal denervation in humans. 36 Previous studies showed that reducing sympathetic activity by renal denervation significantly attenuated atrial effective refractory period shortening and renin-angiotensin-aldosterone system activation, thereby decreasing AF inducibility in a pig model of sleep apnea induced by short-term negative tracheal pressure. 37, 38 These results, together with our own, demonstrated the importance of the autonomic nervous system in both short-and long-term OSA-induced AF. Therefore we speculate that modulation of the sympathetic nervous system might help to prevent AF in patients with OSA, which needs to be clarified in future clinical studies. According to the apnea-hypopnea index value, the severity of OSA in our present animal model is mild. Therefore, our findings suggest that exposure to mild chronic intermittent hypoxia could induce proarrhythmic cardiac remodeling. Our result is consistent with that of Ray et al, 39 who reported that mild intermittent hypoxia for 2 weeks in Wistar rats evoked significant cardiovascular pathophysiology. Limited clinical data are available to assess the association of mild OSA with the risk of atrial fibrillation or other arrhythmias 40 . Further clinical investigation will be required to validate the applicability of our findings to humans.
Limitations
Some limitations should be acknowledged when considering the results of the present study. First, although our data indicated the inhibiting effect of metoprolol on adipokine secretion of EAT induced by OSA, the precise molecular mechanism is still unclear and needs further investigation. Second, 3T3-L1 adipocytes were used to investigate the effect of hypoxia on adipokine secretion in this study. Although our findings from the 3T3-L1 cells more closely mimic the changes observed in vivo, the potential difference in the characteristics between 3T3-L1 cells and canine epicardial adipocytes should not be ignored. Third, the changes in hemodynamic parameters, AF inducibility, and electrophysiological parameters were not examined, and additional work is needed to clarify the influence of EAT on atrial electrophysiological properties.
Conclusions
In summary, our work provided convincing experimental evidence, for the first time, that chronic OSA enhanced the profibrotic effect of EAT on the neighboring atrial myocardium. Hypoxia-induced profibrotic adipokine secretion from EAT might be the main mechanism of the fibrosispromoting effect. Metoprolol significantly attenuated hypoxia-induced adipokine secretion and thereby inhibited the profibrotic effect of EAT enhanced by OSA. This study gives insights into mechanisms underlying OSA-induced AF and also provides experimental evidence for the protective effects of metoprolol.
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